More than 2 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today. Recent data from the American Cancer Society show that for all men with prostate cancer, the relative five-year survival rate is nearly 100 percent and the relative 10-year survival rate is 91 percent.
The prostate cancer experts at Holden Comprehensive Cancer Center stay on top of the latest cancer diagnosis methods and treatments to help improve the odds for your cancer survival.
Experts at Holden Comprehensive Cancer Center understand prostate cancer and work as a team to design the best treatment plan. A typical team is made up of surgical, medical, and radiation oncologists, as well as urologists, social workers, and nurses. Treatment plans may include:
Hormone therapy - often used in conjunction with radiation therapy for patients who have either intermediate or high-risk prostate cancer.
Immunotherapy (biological therapy) - works to boost, direct, or restore your body's natural defenses against disease.
Radiation therapy - external or internal beam
Prostatectomy - removal of the prostate. Traditional and minimally invasive options available.
Palliative surgery - surgery to relieve symptoms if the cancer has spread and cannot be removed
Watchful observation, without treatment, may also be an option for some individuals.